Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03335072 · ClinicalTrials.gov registry record · Phase 4
Kebele Elimination of Trachoma for Ocular Health
A Phase 4 study of Trachoma, sponsored by University of California, San Francisco.
- Active
- Registry status
- Phase 4
- Development phase
- 320,000
- Enrollment target
- 2
- Study locations
NCT03335072 is a Phase 4 study of Trachoma that is active but no longer recruiting, run by University of California, San Francisco. The registered enrollment target is 320,000 participants, above the 565-participant average among 4 other Trachoma trials with a reported enrollment target (56537% higher). The trial reports 2 study locations across 2 states.
The verdict
NCT03335072, a Phase 4 study of Trachoma, is active but no longer recruiting, sponsored by University of California, San Francisco.
- ACTIVE NOT RECRUITING
- Registry status
- Phase 4
- Development phase
- 320,000 participants
- Enrollment target
- 2
- Study locations
Study Summary
The investigators propose a cluster-randomized clinical trial to determine whether an intensive, targeted azithromycin distribution strategy is effective for elimination of trachoma at the kebele level compared to the World Health Organization (WHO) recommendation of annual azithromycin distribution.
Conditions Studied
Interventions
- DRUG Azithromycin
Study Locations (2)
California
- UCSF Proctor Foundation - San Francisco
Other
- Eyu-Ethiopia - Bahir Dar
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 320,000 participants |
| Start Date | 2022-02-07 |
| Est. Completion | 2028-03-01 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03335072
The ClinicalTrials.gov registry entry for NCT03335072 describes a study currently listed as active not recruiting, categorized as Phase 4. The registered enrollment target is 320,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 565-participant average among 4 other Trachoma trials with a reported enrollment target (56537% higher). The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Trachoma appearing as the primary indexed condition, and to 1 intervention - of which Azithromycin is the first listed.
NCT03335072 reports 2 study locations spanning 2 distinct geographic areas - top geographies include California, Other.
Frequently Asked Questions
What is clinical trial NCT03335072 about?
NCT03335072 is a clinical study titled "Kebele Elimination of Trachoma for Ocular Health". The investigators propose a cluster-randomized clinical trial to determine whether an intensive, targeted azithromycin distribution strategy is effective for elimination of trachoma at the kebele level compared to the World Health Organization (WHO) recommendation of annual azithromycin distribution...
What is the current status of trial NCT03335072?
This trial is currently active not recruiting. It is a Phase 4 study. The enrollment target is 320,000 participants. The study started on 2022-02-07. Estimated completion is 2028-03-01.
What conditions does trial NCT03335072 study?
This clinical trial studies the following conditions: Trachoma.
What interventions are being tested in trial NCT03335072?
The interventions under investigation include: Azithromycin (DRUG).
Who is sponsoring clinical trial NCT03335072?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03335072 being conducted?
This trial has 2 study locations across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Trachoma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Effect of Intensive Fly Control on Trachoma and Ocular Chlamydia Infection in Tanzania
COMPLETED · Phase 4
-
Impact of Two Alternative Dosing Strategies for Trachoma Control in Niger
COMPLETED · Phase 4
-
Impact of Water and Health Education Programs on Trachoma and Ocular C. Trachomatis in Niger
COMPLETED · Phase 4
-
A Surveillance and Azithromycin Treatment for Newcomers and Travelers Evaluation: The ASANTE Trial
COMPLETED · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.